McKesson PE Ratio 2010-2024 | MCK

Current and historical p/e ratio for McKesson (MCK) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. McKesson PE ratio as of May 22, 2024 is 20.33.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

McKesson PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-05-22 557.38 24.91
2024-03-31 536.85 $22.38 23.99
2023-12-31 462.43 $22.07 20.95
2023-09-30 434.33 $25.31 17.16
2023-06-30 426.16 $26.81 15.90
2023-03-31 354.60 $25.11 14.12
2022-12-31 373.02 $21.87 17.06
2022-09-30 337.49 $14.17 23.82
2022-06-30 323.45 $9.46 34.19
2022-03-31 303.11 $8.29 36.56
2021-12-31 245.69 $-33.21 0.00
2021-09-30 196.65 $-29.63 0.00
2021-03-31 191.09 $-28.62 0.00
2020-12-31 169.99 $-26.92 0.00
2020-09-30 145.22 $15.18 9.57
2020-06-30 149.19 $12.67 11.78
2020-03-31 131.19 $5.96 22.01
2021-06-30 188.19 $2.35 80.08
2019-12-31 133.77 $-4.89 0.00
2019-09-30 131.79 $-3.52 0.00
2019-06-30 129.22 $2.98 43.36
2019-03-31 112.20 $0.06 1869.94
2018-12-31 105.56 $-1.35 0.00
2018-09-30 126.35 $0.58 217.85
2018-06-30 126.68 $-1.92 0.00
2018-03-31 133.46 $0.22 606.63
2017-12-31 147.41 $22.57 6.53
2017-09-30 144.86 $21.09 6.87
2017-06-30 154.81 $22.42 6.91
2017-03-31 139.26 $23.34 5.97
2016-12-31 131.68 $8.45 15.58
2016-09-30 156.03 $8.33 18.73
2016-06-30 174.38 $9.62 18.13
2016-03-31 146.70 $9.69 15.14
2015-12-31 183.67 $8.37 21.94
2015-09-30 172.05 $7.64 22.52
2015-06-30 208.75 $7.00 29.82
2015-03-31 209.83 $6.27 33.47
2014-12-31 192.35 $7.29 26.39
2014-09-30 180.18 $5.57 32.35
2014-06-30 172.14 $5.32 32.36
2014-03-31 163.02 $5.43 30.02
2013-12-31 148.81 $4.95 30.06
2013-09-30 118.12 $5.91 19.99
2013-06-30 105.21 $5.84 18.01
2013-03-31 99.02 $5.59 17.71
2012-12-31 88.76 $6.58 13.49
2012-09-30 78.59 $6.54 12.02
2012-06-30 85.45 $6.05 14.12
2012-03-31 79.81 $5.60 14.25
2011-12-31 70.68 $5.13 13.78
2011-09-30 65.78 $4.53 14.52
2011-06-30 75.50 $4.60 16.41
2011-03-31 71.18 $4.57 15.57
2010-12-31 63.23 $4.21 15.02
2010-09-30 55.35 $4.80 11.53
2010-06-30 59.98 $4.66 12.87
2010-03-31 58.54 $4.62 12.67
2009-12-31 55.56 $4.37 12.71
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $72.451B $308.951B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $67.758B 19.17
West Pharmaceutical Services (WST) United States $24.351B 43.64
Cardinal Health (CAH) United States $23.460B 13.41
Align Technology (ALGN) United States $19.658B 37.95
Cooper (COO) United States $19.200B 29.05
Labcorp (LH) United States $16.960B 14.60
Henry Schein (HSIC) United States $9.268B 16.49
DENTSPLY SIRONA (XRAY) United States $5.824B 15.08
Merit Medical Systems (MMSI) United States $4.773B 26.16
CONMED (CNMD) United States $2.309B 20.94
Patterson (PDCO) United States $2.193B 10.51
STAAR Surgical (STAA) United States $2.091B 80.28
Atrion (ATRI) United States $0.831B 44.36
Lifevantage (LFVN) United States $0.095B 12.25
Pro-Dex (PDEX) United States $0.067B 33.88
Biolase (BIOL) United States $0.006B 0.00